Immunosuppressive Agents: all 5,940 studies that test it
Page 34 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- A Study to Assess Efficacy and Safety of Nasacort® Nasal Spray in Comparison With Flixonase® Nasal Spray in Adults Suffering From Perennial Allergic Rhinitis (PAR)CompletedNCT03317015Phase 3
- Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant TumorsStatus unknownNCT03302403Not applicable
- Secondary Prevention Trial of Rapamycin in Patients With Resected Non-muscle Invasive Bladder CancerWithdrawnNCT03298958Phase 3
- A Study to Evaluate SIMPONI (Golimumab) Therapy in Children, Adolescents and Young Adults With Pre-Symptomatic Type 1 DiabetesCompletedNCT03298542Phase 1
- Safety and Bioequivalence of Pimecrolimus Cream 1% and Elidel R in Treatment of Mild to Moderate Atopic DermatitisCompletedNCT03297502Phase 3
- Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBCCompletedNCT03289819Phase 2
- ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016Active, not recruitingNCT03286634Phase 2
- Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene MutationCompletedNCT03285802Phase 2/3
- Pharmacokinetic, Safety and Tolerability Study of Altebrel in Healthy Male SubjectsCompletedNCT03273088Phase 1
- Envarsus XR® in Adolescent Renal Transplant RecipientsActive, not recruitingNCT03266393Phase 4
- Twice-daily Tacrolimus and Everolimus Convert to Once-daily Tacrolimus and Everolimus in Liver Transplant RecipientCompletedNCT03256864Phase 4
- Methotrexate, Blood Pressure and Arterial Function in Rheumatoid ArthritisCompletedNCT03254589Phase 4
- Triamcinolone Levels in Cochlear PerilymphCompletedNCT03248856Phase 1
- Particulate vs. Nonparticulate Epidural Steroid Injections for Lumbar Foraminal StenosisWithdrawnNCT03245671Phase 4
- Food Effect, Oral & Intravenous Pharmacokinetics and Absolute Bioavailability of BAY1834845 Including Drug-drug Interaction With MethotrexateCompletedNCT03244462Phase 1
- The Safety and Efficacy of Pomalidomide in Combination With Cyclophosphamide and Dexamethasone (PCD) in the Transplant-ineligible Patients With Relapsed and/or Refractory Multiple Myeloma (MM)CompletedNCT03242460Phase 2
- Study of CD19/CD22 Chimeric Antigen Receptor T Cells in Children & Young Adults w/ Recurrent or Refractory B Cell MalignanciesActive, not recruitingNCT03241940Phase 1
- Human Penile Tissue Allotransplantation for Devastating Penile and Concomitant Genital TraumaWithdrawnNCT03240822Phase 1
- Efficacy and Safety of Precision Therapy in Refractory TumorStatus unknownNCT03239015Phase 2
- Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL AmyloidosisCompletedNCT03236792Phase 1/2
- The Effect of Fractional Co2 Laser Either With Tacrolimus, Calcipotriol or NB-UVB in Stable Generalized VitiligoStatus unknownNCT03234673Phase 1
- Study of Entospletinib (ENTO) in Newly Diagnosed DLBCL Patients With aaIPI>=1 Treated by ChemiotherapyTerminatedNCT03225924Phase 1/2
- Tacrolimus in Children With Henoch-Schönlein Purpura NephritisCompletedNCT03222687Phase 4
- Thalidomide Versus Infliximab in New Onset Crohn's Disease With Poor Prognostic FactorsTerminatedNCT03221166Phase 3
- Extended Follow-up of Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA NephropathyStatus unknownNCT03218852Phase 4
- MAP Study: Methotrexate and Adalimumab in PsoriasisCompletedNCT03217734Phase 2/3
- Epacadostat (INCB24360) in Combination With Sirolimus in Advanced MalignancyActive, not recruitingNCT03217669Phase 1
- Multicenter Randomized Two-arms Study Evaluating the BK Viral Clearance in Kidney Transplant Recipients With BK Viremia.CompletedNCT03216967Phase 4
- The Therapeutic Effect of Thalidomide in RIStatus unknownNCT03208413Phase 2
- IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma PatientsCompletedNCT03203005Phase 1/2
- Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast CancerTerminatedNCT03202446Phase 3
- Cyclophosphamide Versus Mycophenolate Mofetil in Lupus NephritisCompletedNCT03200002Phase 2
- A Study Investigating the Anti-epileptic Efficacy of Afinitor (Everolimus) in Patients With Refractory Seizures Who Have Focal Cortical Dysplasia Type II (FCD II)CompletedNCT03198949Phase 2
- An Multicentre Clinical Study to Evaluate the Usability and Safety of the Autoinjector and Pre-filled Syringe of SB4 in Subjects With Rheumatoid ArthritisCompletedNCT03193957Phase 2
- Pharmacokinetics, Safety, and Tolerability Study of the Autoinjector and Pre-filled Syringe of SB4 in Healthy Male SubjectsCompletedNCT03193203Phase 1
- A Study to Evaluate Efficacy and Safety of Subcutaneous Abatacept With Steroid Treatment Compared to Steroid Treatment Alone in Adults With Giant Cell Arteritis (GCA)WithdrawnNCT03192969Phase 3
- Basiliximab Treating Interstitial Pneumonia of CADMStatus unknownNCT03192657Phase 2
- Pembrolizumab Cyclophosphamide and Lenalidomide for Patients With Relapsed Multiple MyelomaWithdrawnNCT03191981Phase 1/2
- Evaluation of Different Benznidazole Regimens for the Treatment of Chronic Chagas Disease.CompletedNCT03191162Phase 2
- A Optimal Anti-Thymoglobuline (ATG) Dose Decrease cGVHD But Not Increase Leukemia Relapse for Haplo-HSCTStatus unknownNCT03190733Phase 4
- Risk Adapted Therapy in Diffuse Large B Cell LymphomaStatus unknownNCT03188198Phase 2
- MUK Nine b: OPTIMUM Treatment ProtocolActive, not recruitingNCT03188172Phase 2
- The Effective and Safety of Thalidomide in TIStatus unknownNCT03184844Phase 2
- Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose OptimizationCompletedNCT03182166Phase 2
- Cladribine in Combination With CAG in Patients With Refractory/Relapsed Acute Myeloid LeukemiaStatus unknownNCT03181815Phase 2
- Open-label Study on Treatment of Primary Aldosteronism With EverolimusCompletedNCT03174171Phase 2
- Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Thalassemia MajorStatus unknownNCT03171831Phase 4
- Immunomodulatory Effects of Rapamycin on Pregnancy Rate of Patient With Recurrent Implantation FailureCompletedNCT03161340Phase 2
- Metronomic Chemotherapy in Elderly Non-fit Patients With Aggressive B-Cell LymphomasCompletedNCT03161054Phase 2
- An Efficacy and Safety Study of Subcutaneous Tocilizumab in Combination With Methotrexate (MTX) and as Monotherapy Versus MTX in Participants With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Current Disease-Modifying Antirheumatic Drug (DMARD) TherapyCompletedNCT03155347Phase 3
- Chidamide Combined With Clad/Gem/Bu With AutoSCT in R/R Diffuse Large B Cell LymphomaStatus unknownNCT03151876Phase 2
- Two Therapeutic Strategies for the Maintenance of Remission in Patients With Ulcerative ColitisStatus unknownNCT03151525Phase 4
- Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease TrialActive, not recruitingNCT03150914Phase 3
- Early Tapering of Immunosuppressive Agents to Immunomodulation to Improve Survival of AML PatientsStatus unknownNCT03150134Phase 4
- The p53 Colorectal Cancer TrialTerminatedNCT03149679Phase 2
- Impact of Concomitant MTX on Efficacy, Safety and Adherence of Ustekinumab-treatment in Patients With Active PsACompletedNCT03148860Phase 3
- Daratumumab, Thalidomide and Dexamethasone in Relapse and/or Refractory MyelomaStatus unknownNCT03143036Phase 2
- Carfilzomib Thalidomide and Dexamethasone in Patients With Relapsed and/or Refractory Multiple MyelomaStatus unknownNCT03140943Phase 2
- Topical Rapamycin and Calcitriol for Angiofibroma of Tuberous SclerosisCompletedNCT03140449Phase 3
- Evaluation of Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated With Metronomic CyclophosphamideCompletedNCT03139851Phase 2
- UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib AloneSuspendedNCT03139747Phase 2
- Cyclophosphamide and Alemtuzumab In LymphomaTerminatedNCT03132584Phase 1
- Study of Adoptive Cellular Therapy Using Autologous T Cells Transduced With Lentivirus to Express a CD33 Specific Chimeric Antigen Receptor in Patients With Relapsed or Refractory CD33-Positive Acute Myeloid LeukemiaTerminatedNCT03126864Phase 1
- High-dose Intravenous Methotrexate Versus Intrathecal Methotrexate for Central Nervous System Prophylaxis in DLBCLStatus unknownNCT03123718Phase 3
- Randomized, Double-blinded Study of Treatment:Teriflunomide, in Radiologically Isolated SyndromeCompletedNCT03122652Phase 3
- Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Secondary MyelofibrosisActive, not recruitingNCT03118492Phase 1
- Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and LymphomaActive, not recruitingNCT03117751Phase 2/3
- Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)Active, not recruitingNCT03114527Phase 2
- Prospective Study of Deep Anterior Lamellar Keratoplasty Using Acellular Porcine CorneaStatus unknownNCT03105466Not applicable
- Novel Compositions for Treating or Preventing Dermal DisordersCompletedNCT03103893Phase 1/2
- Beneficial and Harmful Effects of Azathioprine and Allopurinol Versus Standard Azathioprine Therapy for Patients With Ulcerative ColitisStatus unknownNCT03101800Phase 3
- A Study of Thymoglobuline® Induction Therapy in Adult Recipients of Donated After Cardiac Death Kidney TransplantCompletedNCT03099122Phase 4
- Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's ArteritisCompletedNCT03096275Phase 3
- Drug/Drug Interactions With F901318WithdrawnNCT03095547Phase 1
- BCMA Chimeric Antigen Receptor Expressing T Cells in Multiple MyelomaStatus unknownNCT03093168Phase 1
- Investigating Indirect Mechanism of Neuroprotection of Tecfidera® (Dimethyl Fumarate) in RRMS and Progressive PatientsStatus unknownNCT03092544Phase 4
- Haploidentical Stem Cell Transplantation Using Post-Transplant CyclophosphamideTerminatedNCT03088709Phase 2
- Cyclophosphamide vs. Infliximab for Refractory Idiopathic Scleritis (CIRIS)WithdrawnNCT03088293Phase 3
- Efficacy and Safety of Rabbit Antithymocyte Globulin 3mg/kg in Kidney Transplant Patients Under Steroid-free and CNI Minimization Maintenance Immunosuppressive RegimenStatus unknownNCT03088280Phase 4
- APRIL (AbatacePt in Rheumatoid Arthritis-ILD)Status unknownNCT03084419Phase 2
- Drug Interaction Study of Apixaban With Cyclosporine and TacrolimusCompletedNCT03083782Phase 1
- Pharmacokinetic Study of Adoport® (Tacrolimus) in Patients With de Novo Kidney TransplantationCompletedNCT03076151Phase 4
- Phase 1 Study of the Effects of Combining Topical FDA-approved Drugs on Age-related Pathways on the Skin of Healthy VolunteersCompletedNCT03072485Phase 1
- Corticosteroid Injection in Carpal Tunnel SyndromeCompletedNCT03072290Not applicable
- A Clinical Study to Test the Effects of Ruxolitinib And Thalidomide Combination for Patients With MyelofibrosisActive, not recruitingNCT03069326Phase 2
- Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Uveal MelanomaActive, not recruitingNCT03068624Phase 1
- Neratinib and Everolimus, Palbociclib, or Trametinib in Treating Participants With Refractory and Advanced or Metastatic Solid Tumors With EGFR Mutation/Amplification, HER2 Mutation/Amplification, or HER3/4 Mutation or KRAS MutationTerminatedNCT03065387Phase 1
- Clinical Trial Evaluating Metronomic Chemotherapy in Patients With Metastatic OsteosarcomaStatus unknownNCT03063983Phase 2
- Study of Thalidomide in Treatment of Advanced Nsclc (Dream-003)Status unknownNCT03062800Phase 2
- Tandem High Dose Chemotherapy With 131I-MIBG Treatment in High Risk NeuroblastomaStatus unknownNCT03061656Phase 2
- Trial of Orencia in Patients With Myasthenia GravisTerminatedNCT03059888Early Phase 1
- Efficacy of Starting Methotrexate Early in Chikungunya ArthritisCompletedNCT03058471Not applicable
- Comparison of Cyclic On-off and Continuous Excimer Laser Treatment for VitiligoCompletedNCT03047733Not applicable
- PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated MalignanciesStatus unknownNCT03044743Phase 1/2
- Prediction of the Answer to the Treatment by Biotherapies for Naive Spondyloarthritis by Combinatorial Analysis of Serum BiomarkersCompletedNCT03033095Not applicable
- A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing ToxicityCompletedNCT03032783Phase 2
- A Study of CD19 Redirected Autologous T Cells for CD19 Positive Systemic Lupus Erythematosus (SLE)Status unknownNCT03030976Phase 1
- Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube CancerActive, not recruitingNCT03029403Phase 2
- Alitretinoin vs Cyclosporine in Severe Recurrent Vesicular Hand EczemaStatus unknownNCT03026946Phase 3
- Alitretinoin vs Azathioprine in Severe Non-hyperkeratotic Hand EczemaStatus unknownNCT03026907Phase 3